Drugs / FLT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04162665 Background | Feb 2020 → Dec 2023 | gastric adenocarcinoma | Washington University School of Medicine | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLT | “The recommendations are CAPOX, FOLFOX, or FLT.” NCT04162665 ↗ |